Back for more: Will Pfizer top its AstraZeneca bid?

Pfizer's $110 billion bid for AstraZeneca was one of the biggest business stories of 2014 - so could a new bid be one of the biggest stories in 2015?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.